Health
Could CRISPR be used as a SARS-CoV-2 antiviral? – News-Medical.Net
The potential of using this gene manipulation technology as a SARS-CoV-2 inhibitor or prophylactic is investigated in a review recently uploaded to the journal…
The CRISPR-Cas system is capable of editing DNA and RNA in situ in living organisms, and as an antiviral agent, can specifically identify and target nucleic acid sequences originating from a pathogen.
The potential of using this gene manipulation technology as a SARS-CoV-2 inhibitor or prophylactic is investigated in a review recently uploaded to the journal Experimental Biology and Medicine (April 25th, 2021) by Arnab Banerjee and colleagues.
CRISPR-Cas systems have been developed for a variety…
-
Business20 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Noosa News15 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News15 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
General6 hours agoDefence minister won’t say if security agencies or Trump administration pushed for Darwin Port backflip